Autoimmune Diseases
Conference Coverage
CC-220 shows efficacy, safety concerns in phase II SLE trial
The investigational agent CC-220 showed some efficacy but also important safety caveats in a 12-week, phase II trial.
Conference Coverage
SLE linked to subsequent risk of malignant melanoma
PORTLAND, ORE. – An analysis of electronic medical records has identified another malignancy associated with systemic lupus erythematosus.
Conference Coverage
Cutaneous manifestations can signify severe systemic disease in ANCA-associated vasculitis
PORTLAND, ORE. – New study results provide information about the types of skin lesions that are a marker for disease severity in patients with...
Conference Coverage
JAK inhibitors and alopecia: After positive early data, various trials now underway
PORTLAND, ORE. - Studies include patients with alopecia areata and its variants, and both topical and oral formulations of ruxolitinib and...
From the Journals
TNFSF13B variant linked to MS and SLE
A variant in the TNFSF13B gene has been linked to susceptibility to both multiple sclerosis and systemic lupus erythematosus, according to a...
News from the FDA/CDC
FDA grants breakthrough therapy status to rituximab for pemphigus vulgaris
The FDA designation is based on the results of a recently published French study.
Conference Coverage
Tree nut allergy responds to immunotherapy
Long-term walnut oral immunotherapy induces clinically relevant treatment response in tree nut allergic children.
Conference Coverage
VIDEO: Don’t overlook psychosocial concerns of vitiligo patients
ORLANDO – There are ways to assess the psychosocial needs of patients with vitiligo.
Conference Coverage
For bullous pemphigoid, doxycycline noninferior to prednisolone, but safer
ORLANDO – Doxycycline effected a cure in 74% of patients with bullous pemphigoid in the BLISTER Trial.
From the Journals
Connective tissue diseases reported in patients receiving immune checkpoint inhibitors
For the first time, new-onset connective tissue disease has been reported in patients who were treated with anti-PD1/PDL-1 agents, according to...
From the Journals
Pediatric lupus patients face large burden of serious infection
Children with systemic lupus erythematosus have high rates of serious infections requiring hospitalization, especially those with lupus nephritis...